Here are the latest quarterly results of NATCO PHARMA. For more details, see the NATCO PHARMA financial fact sheet and NATCO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 5,968 | 8,846 | 4,321 | 4,925 | 8,979 | 11,405 | 10,314 | 7,586 | |
Other income | Rs m | 138 | 343 | 205 | 208 | 290 | 197 | 294 | 370 | |
Turnover | Rs m | 6,106 | 9,189 | 4,526 | 5,133 | 9,269 | 11,602 | 10,608 | 7,956 | |
Expenses | Rs m | 6,154 | 4,893 | 3,368 | 3,866 | 5,588 | 6,125 | 5,734 | 4,905 | |
Gross profit | Rs m | -186 | 3,953 | 953 | 1,059 | 3,391 | 5,280 | 4,580 | 2,681 | |
Depreciation | Rs m | 381 | 396 | 417 | 415 | 410 | 435 | 436 | 442 | |
Interest | Rs m | 67 | 42 | 38 | 38 | 27 | 42 | 42 | 46 | |
Profit before tax | Rs m | -496 | 3,858 | 703 | 814 | 3,244 | 5,000 | 4,396 | 2,563 | |
Tax | Rs m | 9 | 654 | 135 | 191 | 486 | 797 | 706 | 436 | |
Profit after tax | Rs m | -505 | 3,204 | 568 | 623 | 2,758 | 4,203 | 3,690 | 2,127 | |
Gross profit margin | % | -3.1 | 44.7 | 22.1 | 21.5 | 37.8 | 46.3 | 44.4 | 35.3 | |
Effective tax rate | % | -1.8 | 17.0 | 19.2 | 23.5 | 15.0 | 15.9 | 16.1 | 17.0 | |
Net profit margin | % | -8.5 | 36.2 | 13.1 | 12.6 | 30.7 | 36.9 | 35.8 | 28.0 | |
Diluted EPS | Rs | -2.8 | 17.9 | 3.2 | 3.5 | 15.4 | 23.5 | 20.6 | 11.9 | |
Diluted EPS (TTM) | Rs | 9.5 | 23.2 | 22.7 | 21.7 | 39.9 | 45.5 | 62.9 | 71.3 | |
Subscriber Feature |
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.